专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

FR351545A 未知
公开(公告)号：FR351545A
公开(公告)日：1905-07-19
申请号：FR351545D
申请日：1905-02-15
申请人： ROBERT HODGES BISHOP , WILLIAM DOWN , LYONEL EDWIN CLARK , SYDNEY FRANCIS STAPLES
发明人： BISHOP ROBERT HODGES , DOWN WILLIAM , CLARK LYONEL EDWIN , STAPLES SYDNEY FRANCIS
IPC分类号： G07F17/10

2. 发明专利

FR333740A 未知
公开(公告)号：FR333740A
公开(公告)日：1903-12-02
申请号：FR333740D
申请日：1903-06-08
申请人： CHESTER EDWIN CLARK
发明人： CLARK CHESTER EDWIN
IPC分类号： A42C5/00

3. 发明专利

FR505691A 未知
公开(公告)号：FR505691A
公开(公告)日：1920-08-04
申请号：FR505691D
申请日：1916-09-05
申请人： JONAS ALBERT SPARKS , CHARLES EDWIN CLARK , WILLIAM MOORE CLARK
发明人： SPARKS JONAS ALBERT , CLARK CHARLES EDWIN , CLARK WILLIAM MOORE
IPC分类号： B04B15/08

4. 发明专利

AU335211B Improvements relating to building construction 未知
公开(公告)号：AU335211B
公开(公告)日：1912-03-05
申请号：AU335211
申请日：1911-12-14
申请人： THOMAS EDWIN CLARK
发明人： THOMAS EDWIN CLARK

5. 发明专利

FR337331A 未知
公开(公告)号：FR337331A
公开(公告)日：1904-04-04
申请号：FR337331D
申请日：1903-11-06
申请人： ROBERT HODGES BISHOP , WILLIAM DOWN , LYONEL EDWIN CLARK , SYDNEY FRANCIS STAPLES
发明人： BISHOP ROBERT HODGES , DOWN WILLIAM , CLARK LYONEL EDWIN , STAPLES SYDNEY FRANCIS
IPC分类号： G07F17/10

6. 发明申请

US20120141604A1 NOVEL COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF HUMAN CANCERS 审中-公开
标题翻译：人类癌症鉴定，评估，预防和治疗的新组合物和方法
公开(公告)号：US20120141604A1
公开(公告)日：2012-06-07
申请号：US13289230
申请日：2011-11-04
申请人： Edwin Clark , Tallessyn Grenfell-Lee , Karen Lu , Lynn Hartmann , Jeffrey L. Brown , Robert C. Bast, JR. , Gordon B. Mills
发明人： Edwin Clark , Tallessyn Grenfell-Lee , Karen Lu , Lynn Hartmann , Jeffrey L. Brown , Robert C. Bast, JR. , Gordon B. Mills
IPC分类号： C40B30/04 , A61K33/24 , A61P35/00 , A61K31/337
CPC分类号： G01N33/6893 , C12Q1/6886 , C12Q2600/106 , C12Q2600/136 , C12Q2600/158 , G01N33/57496 , G01N2500/00 , G01N2800/52
摘要： The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.
摘要翻译：本发明涉及可用于确定肿瘤是否对治疗剂敏感或抗性的标志物的鉴定。本发明还涉及治疗靶标的鉴定。本发明特征在于许多“灵敏度标记物”。这些标记物在大多数或所有细胞系中表达，对于用药物治疗敏感并且在细胞中未表达（或以相当低的水平表达）耐药性。本发明还具有许多“抗性标记”。这些标记物在大多数或所有细胞系中表达，其对于用药剂治疗有抗性并且在细胞中不表达（或以相当低的水平表达）对该药物的治疗敏感。本发明还具有可以预测可能响应或不响应于药剂的患者的标记物组。

7. 发明申请

US20110104306A1 NOVEL COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF HUMAN CANCERS 失效
标题翻译：人类癌症鉴定，评估，预防和治疗的新组合物和方法
公开(公告)号：US20110104306A1
公开(公告)日：2011-05-05
申请号：US12956500
申请日：2010-11-30
申请人： Edwin Clark , Tallessyn Grenfell-Lee , Karen Lu , Lynn Hartmann , Jeffrey L. Brown
发明人： Edwin Clark , Tallessyn Grenfell-Lee , Karen Lu , Lynn Hartmann , Jeffrey L. Brown
IPC分类号： A61K33/24 , C12Q1/02 , C12Q1/68 , A61P35/00 , A61K31/337
CPC分类号： G01N33/6893 , C12Q1/6886 , C12Q2600/106 , C12Q2600/136 , C12Q2600/158 , G01N33/57496 , G01N2500/00 , G01N2800/52
摘要： The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.
摘要翻译：本发明涉及可用于确定肿瘤是否对治疗剂敏感或抗性的标志物的鉴定。本发明还涉及治疗靶标的鉴定。本发明特征在于许多“灵敏度标记物”。这些标记物在大多数或所有细胞系中表达，对于用药物治疗敏感并且在细胞中未表达（或以相当低的水平表达）耐药性。本发明还具有许多“抗性标记”。这些标记物在大多数或所有细胞系中表达，其对于用药剂治疗有抗性并且在细胞中不表达（或以相当低的水平表达）对该药物的治疗敏感。本发明还具有可以预测可能响应或不响应于药剂的患者的标记物组。

8. 发明申请

US20080286780A1 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers 失效
标题翻译：用于鉴定，评估，预防和治疗人类癌症的新型组合物和方法
公开(公告)号：US20080286780A1
公开(公告)日：2008-11-20
申请号：US12002783
申请日：2007-12-17
申请人： Edwin Clark , Tallessyn Grenfell-Lee , Karen Lu , Lynn Hartmann , Jeffrey L. Brown
发明人： Edwin Clark , Tallessyn Grenfell-Lee , Karen Lu , Lynn Hartmann , Jeffrey L. Brown
IPC分类号： C12Q1/68 , C12Q1/02 , G01N33/574
CPC分类号： G01N33/6893 , C12Q1/6886 , C12Q2600/106 , C12Q2600/136 , C12Q2600/158 , G01N33/57496 , G01N2500/00 , G01N2800/52
摘要： The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.
摘要翻译：本发明涉及可用于确定肿瘤是否对治疗剂敏感或抗性的标志物的鉴定。本发明还涉及治疗靶标的鉴定。本发明具有许多“灵敏度标记”。这些标记物在大多数或所有细胞系中表达，其对于用药物治疗敏感并且在对该药物治疗有抗性的细胞中不表达（或以相当低的水平表达）表达。本发明还具有许多“电阻标记”。这些是在大多数或所有细胞系中表达的标记，其对于用药物治疗是有抗性的，并且在对用该药物治疗敏感的细胞中不表达（或以相当低的水平表达）表达。本发明还具有可以预测可能响应或不响应于药剂的患者的标记物组。

9. 发明申请

US20060121511A1 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents 审中-公开
标题翻译：用于确定对微管稳定剂的敏感性的生物标志物和方法
公开(公告)号：US20060121511A1
公开(公告)日：2006-06-08
申请号：US11289102
申请日：2005-11-29
申请人： Hyerim Lee , Peter Shaw , Edwin Clark
发明人： Hyerim Lee , Peter Shaw , Edwin Clark
IPC分类号： C12Q1/68 , G01N33/574
CPC分类号： G01N33/574 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/57415 , G01N33/57484 , G01N2800/52
摘要： Biomarkers that are useful for identifying a mammal that will respond therapeutically or is responding therapeutically to a method of treating cancer that comprises administering a microtubule-stabilizing agent. In one aspect, the cancer is breast cancer, and the microtubule-stabilizing agent is an epothilone or analog or derivative thereof, or ixabepilone.
摘要翻译：可用于鉴定将对治疗癌症的治疗方法进行治疗或反应的哺乳动物有用的生物标志物，其包括施用微管稳定剂。一方面，癌症是乳腺癌，并且微管稳定剂是埃坡霉素或其类似物或衍生物，或ixabepilone。

10. 发明授权

US3676984A Drilling mud degasser 失效
标题翻译：钻井泥浆机
公开(公告)号：US3676984A
公开(公告)日：1972-07-18
申请号：US3676984D
申请日：1970-10-22
申请人： JOSEPH EDWIN CLARK
发明人： CLARK JOSEPH EDWIN
IPC分类号： B01D19/00 , E21B21/06
CPC分类号： E21B21/067 , B01D19/0021
摘要： A novel inlet and baffle structure for a drilling and degasser is provided. Gas-cut mud is fed into the degasser vacuum chamber through a horizontal inlet pipe having a long slot cut in its bottom wall. The mud flow is formed into a thin curtain as it passes through this slot. At the same time, its rate of movement is accelerated, with a consequent increase in shear and drop in viscosity. The mud immediately contacts a generally horizontal baffle. The flow is divided into two turbulent, thin layers. It is then conducted through a system of baffles. Due to the change in mud viscosity, induced turbulence and the forming of the mud flow into thin layers of large area, the vacuum within the chamber is able to effectively separate the entrained gas from the mud.
摘要翻译：提供了一种用于钻孔和脱气机的新型入口和挡板结构。气体切割泥浆通过其底壁中具有长槽切割的水平入口管进入脱气器真空室。泥浆流通过这个槽时形成一个薄的窗帘。同时，其运动速度加快，随之而来的剪切和粘度下降。泥浆立即接触一个大致水平的挡板。流动分为两层湍流薄层。然后通过挡板系统进行。由于泥浆粘度的变化，引起的湍流和泥浆流形成大面积的薄层，室内的真空能够有效地将夹带的气体与泥浆分离。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式